AQP4 and autoimmune polyendocrinopathy: Of six participants with AQP4 antibodies who developed APS after their initial presentation, four showed isolated APS as main phenotype of relapse (two of four with brain MRI at the time of relapse had no or only non-specific brain lesion except area postrema lesion).